SecProbe.io - Probe Score Transparency

Probe Score Transparency

Kymera Therapeutics, Inc. (KYMR)
Score window: Apr. 15, 2025 to Apr. 14, 2026

Back View Correspondence

Probe Score

3.5 / 10

Letters

2

Latest Activity

May. 7, 2025

Version

v1

Score Breakdown

Letter Count

2.0

Sentiment / Tone

1.5

Keywords

0.0

Signals

0.0

Notable 8-K Modifier

0.0

Notable 8-K Count

0

Matched Signals

No stored keyword or signal matches were recorded for this score.

Filings In This Window

Date	Form	Sentiment	Urgency	Summary	Open
May. 7, 2025	UPLOAD	Neutral/Informational	Low	The SEC has completed its review of Kymera Therapeutics, Inc.'s Form 10-K for the fiscal year ended December 31, 2024. They remind the company that it is responsible for the accur…	Read Filing EDGAR
Apr. 30, 2025	CORRESP	Concern from SEC	Moderate	Kymera Therapeutics, Inc. submitted a response to the SEC's comments regarding their Form 10-K for the fiscal year ended December 31, 2024. The SEC raised concerns about the compa…	Read Filing EDGAR
Apr. 25, 2025	UPLOAD	Concern from SEC	High	The SEC has issued a comment letter to Kymera Therapeutics regarding their Form 10-K for the fiscal year ended December 31, 2024. The SEC is specifically concerned about the discl…	Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in the score window.